Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4531

A TRIAL OF LOW DOSE NALTREXONE AND KETAMINE CREAM FOR DIFFUSE CUTANEOUS NEUROPATHIC PAIN

Part of Topic

Medically Challenging Cases

A Trial of Low Dose Naltrexone and Ketamine Cream for Diffuse Cutaneous Neuropathic Pain

Introduction: 

• Neuropathic pain is “initiated or caused by a primary lesion or dysfunction in the nervous system”. Managing neuropathic pain can be challenging
• Low-dose naltrexone has seen recent use in central neuropathic pain states such as: fibromyalgia, complex regional pain syndrome, diabetic neuropathy, and multiple sclerosis (MS).
• Topical ketamine has been used off label for these same conditions.
• We describe a rare case of diffuse cutaneous neuropathic pain that, after failing several different neuropathic agents, was trialed on low-dose naltrexone, and ultimately managed with compounded cream.
 
 
22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.